Breaking News

DifGen Acquires FDA-Registered Manufacturing Facility

Accelerates its portfolio diversification and augments its development capabilities for sterile parenteral and ophthalmic dosage forms.

Author Image

By: Charlie Sternberg

Associate Editor

DifGen Pharmaceuticals LLC has signed and closed an all-cash transaction through its subsidiary Aveva Drug Delivery Systems Inc. to purchase the operating and manufacturing assets of an FDA-registered manufacturing facility located in Tamarac, Florida.   The facility has manufacturing capability to handle solutions/suspension/emulsions through blow-fill-seal, form fill seal technology and traditional filling of liquid and semi-solid products in a variety of dosage forms including stick packs a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters